The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The global PEGylated Protein Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
This report aims to provide a comprehensive presentation of the global market for PEGylated Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylated Protein Therapeutics.
Report Scope
The PEGylated Protein Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PEGylated Protein Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylated Protein Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Merck
- Pfizer
- UCB
- Amgen
- AstraZeneca
- Biogen
- Roche
- Horizon Pharma
- Leadiant Biosciences
Segment by Type
- Colony Stimulating Factor
- Interferon
- Erythropoietin (EPO)
- Recombinant Factor VIII
- Monoclonal Antibody
- Enzyme
- Others
Segment by Application
- Cancer
- Autoimmune Disease
- Hepatitis
- Multiple Sclerosis
- Hemophilia
- Gastrointestinal Disorder
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PEGylated Protein Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PEGylated Protein Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Colony Stimulating Factor
1.2.3 Interferon
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor VIII
1.2.6 Monoclonal Antibody
1.2.7 Enzyme
1.2.8 Others
1.3 Market by Application
1.3.1 Global PEGylated Protein Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Autoimmune Disease
1.3.4 Hepatitis
1.3.5 Multiple Sclerosis
1.3.6 Hemophilia
1.3.7 Gastrointestinal Disorder
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PEGylated Protein Therapeutics Market Perspective (2019-2030)
2.2 PEGylated Protein Therapeutics Growth Trends by Region
2.2.1 Global PEGylated Protein Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PEGylated Protein Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 PEGylated Protein Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 PEGylated Protein Therapeutics Market Dynamics
2.3.1 PEGylated Protein Therapeutics Industry Trends
2.3.2 PEGylated Protein Therapeutics Market Drivers
2.3.3 PEGylated Protein Therapeutics Market Challenges
2.3.4 PEGylated Protein Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PEGylated Protein Therapeutics Players by Revenue
3.1.1 Global Top PEGylated Protein Therapeutics Players by Revenue (2019-2024)
3.1.2 Global PEGylated Protein Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global PEGylated Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PEGylated Protein Therapeutics Revenue
3.4 Global PEGylated Protein Therapeutics Market Concentration Ratio
3.4.1 Global PEGylated Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PEGylated Protein Therapeutics Revenue in 2023
3.5 PEGylated Protein Therapeutics Key Players Head office and Area Served
3.6 Key Players PEGylated Protein Therapeutics Product Solution and Service
3.7 Date of Enter into PEGylated Protein Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PEGylated Protein Therapeutics Breakdown Data by Type
4.1 Global PEGylated Protein Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global PEGylated Protein Therapeutics Forecasted Market Size by Type (2025-2030)
5 PEGylated Protein Therapeutics Breakdown Data by Application
5.1 Global PEGylated Protein Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global PEGylated Protein Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PEGylated Protein Therapeutics Market Size (2019-2030)
6.2 North America PEGylated Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PEGylated Protein Therapeutics Market Size by Country (2019-2024)
6.4 North America PEGylated Protein Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PEGylated Protein Therapeutics Market Size (2019-2030)
7.2 Europe PEGylated Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PEGylated Protein Therapeutics Market Size by Country (2019-2024)
7.4 Europe PEGylated Protein Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PEGylated Protein Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific PEGylated Protein Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PEGylated Protein Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific PEGylated Protein Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PEGylated Protein Therapeutics Market Size (2019-2030)
9.2 Latin America PEGylated Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PEGylated Protein Therapeutics Market Size by Country (2019-2024)
9.4 Latin America PEGylated Protein Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PEGylated Protein Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa PEGylated Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PEGylated Protein Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa PEGylated Protein Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck PEGylated Protein Therapeutics Introduction
11.1.4 Merck Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer PEGylated Protein Therapeutics Introduction
11.2.4 Pfizer Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 UCB
11.3.1 UCB Company Detail
11.3.2 UCB Business Overview
11.3.3 UCB PEGylated Protein Therapeutics Introduction
11.3.4 UCB Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.3.5 UCB Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen PEGylated Protein Therapeutics Introduction
11.4.4 Amgen Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.4.5 Amgen Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca PEGylated Protein Therapeutics Introduction
11.5.4 AstraZeneca Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.5.5 AstraZeneca Recent Development
11.6 Biogen
11.6.1 Biogen Company Detail
11.6.2 Biogen Business Overview
11.6.3 Biogen PEGylated Protein Therapeutics Introduction
11.6.4 Biogen Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.6.5 Biogen Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche PEGylated Protein Therapeutics Introduction
11.7.4 Roche Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.7.5 Roche Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Detail
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma PEGylated Protein Therapeutics Introduction
11.8.4 Horizon Pharma Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.8.5 Horizon Pharma Recent Development
11.9 Leadiant Biosciences
11.9.1 Leadiant Biosciences Company Detail
11.9.2 Leadiant Biosciences Business Overview
11.9.3 Leadiant Biosciences PEGylated Protein Therapeutics Introduction
11.9.4 Leadiant Biosciences Revenue in PEGylated Protein Therapeutics Business (2019-2024)
11.9.5 Leadiant Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
